Patents by Inventor Laval Chan

Laval Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
    Patent number: 6960594
    Abstract: A novel compound which inhibits certain integrins, particularly ?v integrins. Additionally, the novel compound may be used in a method of treating tumors or cancer which comprises administering a pharmaceutically effective amount of the compound to a patient. Additionally, the novel compound may be used in a method of inhibiting angiogensis. Finally, a method of producing the novel compound is disclosed.
    Type: Grant
    Filed: January 16, 2002
    Date of Patent: November 1, 2005
    Assignee: Shire BioChem Inc.
    Inventors: Denis Labrecque, Serge Lamothe, Marc Courchesne, Laval Chan, Giorgio Attardo, Karen Meerovitch
  • Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
    Publication number: 20020137947
    Abstract: A novel compound which inhibits certain integrins, particularly &agr;v integrins. Additionally, the novel compound may be used in a method of treating tumors or cancer which comprises administering a pharmaceutically effective amount of the compound to a patient. Additionally, the novel compound may be used in a method of inhibiting angiogensis. Finally, a method of producing the novel compound is disclosed.
    Type: Application
    Filed: January 16, 2002
    Publication date: September 26, 2002
    Applicant: BioChem Pharma Inc.
    Inventors: Denis Labrecque, Serge Lamothe, Marc Courchesne, Laval Chan, Giorgio Attardo, Karen Meerovitch
  • Thiophene integrin inhibitors
    Patent number: 6274620
    Abstract: The present invention comprises compounds that are effective inhibitors of integrins, particularly &agr;v&bgr;3 and &agr;v&bgr;5 integrins. Particularly, the compounds are of formula I and pharmaceutically acceptable salts thereof wherein X,Y1 W, R1 to R5, A and B are defined according to the disclosure herein.
    Type: Grant
    Filed: June 7, 2000
    Date of Patent: August 14, 2001
    Assignee: BioChem Pharma Inc.
    Inventors: Denis Labrecque, Giorgio Attardo, Monica Bubenik, Laval Chan, Sylvie Charron, Réal Denis, Guy Falardeau, Serge Lamothe, Patrice Préville, Boulos Zacharie